Apoptosis, Cell Cycle, And Cancer Flashcards

(34 cards)

1
Q

G1 checkpoint

A

Occurs in response to DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Restriction point

A

Occurs in response to not enough growth factors. This restriction will keep the cell in G0 until GFs are obtained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

G2 checkpoint

A

Ensures duplication integrity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metaphase checkpoint

A

Ensures chromosomes are attached to mitotic spindle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What pathways will cells follow after the cell cycle?

A

Apoptosis, cell proliferation, or cell differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Myc-TF

A

Will drive cell proliferation by activating G1-CDK to phosphorylate Rb. Rb will then release E2F that will move the cell cycle from G1 to S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

E2F drives expression of what?

A

Cyclin E and cyclin A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CDK2 and Rb

A

CDK2 will hyperphosphorylate Rb to activate E2F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cyclin

A

Cyclins must interact with CDK for CDK to be activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is required for full activation of Clycin-CDK?

A

CDK activating kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

WEE1

A

WEE1 will phosphorylate the roof of CDK to prevent cyclin from binding in its active site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CAK

A

In the inactive state, the T loop will be covering the CDK active site. When cyclin binds, the T loop will move out of the active site and CAK will be able to bind and full activate the CDK-cyclin complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

G1 cyclins and CDKs

A

Cyclin D, CDK 4 and 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

G1/S cyclin and CDK

A

Cyclin E and CDK2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

S phase cyclin and CDKs

A

Cyclin A and CDK2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

M phase cyclin and CDK

A

Cyclin A and B, CDK1

17
Q

Cyclin D purpose

A

Helps passage of cells from restriction point to G1

18
Q

Cyclin E purpose

A

Helps cells commit to DNA replication and enter S phase

19
Q

Cyclin A purpose

A

Necessary for initiation of DNA synthesis

20
Q

Cyclin A ad B purpose

A

Necessary for nuclear division during mitosis

21
Q

Cdc25

A

Will dephosphorylate the roof site to increase CDK activity

22
Q

P27

A

Bind CDK and cyclin to inhibit it

CKI

23
Q

APC/C

A

Regulates progression from metaphase to anaphase because Cyclin-S and Cyclin-M need to decrease activity.

Cdc20 will activate so that cyclins can be polyubiquitinated and degraded by proteosomes

24
Q

What normally degrades p53?

A

MDM2 - an E3 ubiquitin ligase

25
P21
Activation of p53 leads to transcription of CKI p21 that will bind and inactive cyclin-CDK and cause cell arrest Can inhibit all cyclin/CDK complexes but is mainly associated with CDK2
26
Pro-apoptotic
P53 BAX,BAK
27
Pro survival
BCL-1, BCL-Xl
28
BRCA1 is a result of a mutation in what receptor?
HER2 to NEU due to a Val —> Gln mutation
29
Mutated p53
Located on chromosome 17 and monitors check points of cell cycle. Mutation is observed in more than 50% of all human tumors
30
RB mutation
Regulates G1 phase of cell cycle. Located on chromosome 13 and seen in retinoblastoma
31
APC mutation
On chr 5, regulates cell proliferation. It’s observed in familial adenomatous polyposis. Leads to colon cancer
32
DCC mutation
Plays a role in cell proliferation, migration, and apoptosis. Located on Chr 18 and mutations are seen in colon cancer
33
BRCA1/BRCA2 mutation
Chromosome 17, plays a role in DNA repair and apoptosis Observed in breast cancer
34
NF-1 mutation
Chr 17. Encodes GAP which will turn off activated RAS protein. Mutations in NF-1 lead to neurofibromatosis